---

---

therapeutics   entities : Novartis ag   

save search

---

Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
RBGPF | News | $53.94 3.53% 6.46% 0 |

Consumer Non-Durables

| 3.61% | O: 0.98% H: 5.46% C: -0.89%
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -2.22% | O: -3.15% H: 0.0% C: -0.61%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -2.44% | O: 0.96% H: 2.38% C: 0.17%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.94% | O: 1.69% H: 0.02% C: -0.74%
RBGLY | News | $10.98 2.0% -2.05% 250 |

Manufacturing

| 3.68% | O: -0.28% H: 2.18% C: 1.99%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 3.78% | O: 4.32% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 0.67% | O: 0.17% H: 1.48% C: 1.43%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 1.53% | O: 0.4% H: 0.0% C: 0.0%
drug astrazeneca set key therapeutics market

---

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 1.11% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -0.43% | O: 2.1% H: 0.0% C: -2.52%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 4.41% | O: -1.46% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 0.89% | O: -1.19% H: 0.52% C: -0.17%
BAX | $40.93 -0.22% 0.0% 3 |

Health Technology

| 2.22% | O: -0.1% H: 0.13% C: -1.08%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 3.79% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 1.23% | O: -2.13% H: 0.0% C: 0.0%
BMRN | $91.2 -0.93% -0.89% 550 |

Health Technology

| 0.68% | O: -0.72% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 3.59% | O: -0.64% H: 0.45% C: -0.04%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 2.82% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 1.41% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 1.6% | O: -3.43% H: 6.21% C: 6.21%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| -2.12% | O: -0.25% H: 1.1% C: -0.17%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 2.67% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -4.79% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.56 0.35% 0.47% 1.1M |

Health Technology

| -17.77% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| -0.07% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 1.11% | O: 0.84% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 5.56% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 2.04% | O: 0.47% H: 0.23% C: -0.99%
CRIS | $14.77 -1.6% -2.07% 3.9K |

Health Technology

| 37.08% | O: 0.7% H: 16.87% C: 16.87%
therapeutics

---

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| Email alert Add to watchlist
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| Email alert Add to watchlist
GMAB | News | $28.47 -0.32% -0.32% 420 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| Email alert Add to watchlist
GNMSF | News | $290.34 0.23% 3.83% 0 |

Health Technology

| Email alert Add to watchlist
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

---

CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-28 (Crawled : 19:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| Email alert Add to watchlist
AVEO | $15.0 0.0% 0 |

Health Technology

| Email alert Add to watchlist
AUTL | $4.21 -6.03% -5.91% 12 |

Health Technology

| Email alert Add to watchlist
medical

---

Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -6.37% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.33% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 2.58% | O: 0.52% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -5.1% | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| -4.95% | O: 0.02% H: 0.51% C: -0.3%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| -3.34% | O: 0.28% H: 1.71% C: -0.3%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -8.24% | O: 0.26% H: 2.03% C: 1.57%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| -4.64% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

---

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.85 -3.27% -3.11% 230 |

Health Technology

| -23.91% | O: 1.58% H: 0.58% C: -0.39%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 3.23% | O: 0.24% H: 0.42% C: 0.4%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| -2.93% | O: 0.49% H: 0.84% C: -0.07%
TGTX | $13.98 -1.9% -1.86% 9.1K |

Health Technology

| -9.46% | O: 0.71% H: 0.39% C: 0.13%
DTIL | $9.82 -4.01% -4.28% 40 |

Health Technology

| -22.98% | O: 0.39% H: 4.22% C: 1.41%
precision business year update financial results

---

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -0.4% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 2.2% | O: -0.08% H: 0.15% C: -0.44%
AUTL | $4.21 -6.03% -5.91% 12 |

Health Technology

| -33.39% | O: 2.53% H: 1.85% C: -2.31%
medical

---

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| -7.74% | O: 0.21% H: 0.97% C: 0.7%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 0.22% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -7.87% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| -1.12% | O: -0.7% H: 0.73% C: -0.16%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| -6.94% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -2.03% | O: -0.02% H: 0.0% C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 62 |

Health Technology

| -5.47% | O: -0.27% H: 1.26% C: 0.84%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.54% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

---

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -3.38% | O: 0.04% H: 0.44% C: -1.51%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -4.18% | O: -2.08% H: 0.13% C: -0.57%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -8.47% | O: 0.36% H: 0.34% C: -0.54%
XFOR | $1.29 4.88% 3.91% 1.6M |

Health Technology

| 33.89% | O: 0.12% H: 0.0% C: -4.98%
EYPT | News | $16.47 -6.26% -6.68% 820K |

Health Technology

| -36.01% | O: 2.56% H: 1.37% C: -4.13%
AQST | $3.9 -8.88% -9.6% 33K |

Health Technology

| -22.47% | O: 1.79% H: 12.3% C: 10.94%
ALKS | $24.65 1.61% 1.62% 600 |

Health Technology

| -14.82% | O: 1.11% H: 0.96% C: 0.65%

---

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.27 -7.78% -8.18% 440K |

| -22.36% | O: 0.0% H: 8.64% C: 8.36%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -4.75% | O: -0.15% H: 0.31% C: 0.06%
BLBD | $34.99 -3.58% -3.6% 80 |

Producer Manufacturing

| 8.4% | O: 1.02% H: 1.29% C: 1.17%
ALVR | $0.78 -1.38% -1.06% 370 |

Health Technology

| 8.3% | O: -1.42% H: 7.9% C: 3.52%
ADAP | $1.08 -5.26% -5.07% 790K |

Health Technology

| -34.15% | O: 3.05% H: 5.92% C: 1.18%
pdufa commercial

---

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 1.13% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -5.2% | O: 0.09% H: 0.39% C: -0.36%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| -2.13% | O: 0.43% H: 0.67% C: 0.21%
BAX | $40.93 -0.22% 0.0% 3 |

Health Technology

| 3.07% | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| -1.88% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 1.97% | O: 1.33% H: 0.0% C: 0.0%
BMRN | $91.2 -0.93% -0.89% 550 |

Health Technology

| 2.59% | O: -0.38% H: 1.79% C: 0.22%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 6.21% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| -13.62% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 2.88% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 3.12% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| -2.2% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.72% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 4.53% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 1.75% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -5.62% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.83 -5.85% -5.99% 0 |

Health Technology

| 1.36% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 5.95% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| -13.23% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K |

Health Technology

| -16.3% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 4.67% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | News | $9.47 -0.21% -1.11% 20K |

Manufacturing

| -18.36% | O: -3.53% H: 3.49% C: 3.4%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.89% | O: -0.59% H: 0.49% C: 0.41%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 4.61% | O: 0.26% H: 0.13% C: -0.18%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 2.37% | O: 0.19% H: 0.46% C: 0.43%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -5.51% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

---

Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published: 2024-01-26 (Crawled : 15:30) - prnewswire.com
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| -9.57% | O: -0.27% H: 0.38% C: 0.07%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.08% | O: 0.29% H: 0.15% C: -0.13%
SRPT | $124.25 6.09% 1.12% 75 |

Health Technology

| 3.52% | O: 0.69% H: 0.12% C: -1.75%
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| -16.39% | O: 0.0% H: 0.35% C: -0.88%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| -12.01% | O: 0.1% H: 0.47% C: 0.39%
market

---

USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio
Published: 2024-01-25 (Crawled : 07:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -11.93% | O: -3.67% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.55% | O: -0.44% H: 0.19% C: -0.08%
tumors gastrointestinal therapeutics growth

---

Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -7.6% | O: 0.39% H: 0.82% C: -0.74%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.71% | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.02 33.33% -8.85% 0 |

Health Technology

| -66.67% | O: -63.33% H: 263.64% C: 127.27%
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| -15.6% | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.21 -6.03% -5.91% 12 |

Health Technology

| -23.73% | O: -0.91% H: 11.52% C: 4.94%
drug report t-cell global therapy market

---

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | News | $53.94 3.53% 6.46% 0 |

Consumer Non-Durables

| -24.28% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -8.83% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 0.33% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | News | $10.98 2.0% -2.05% 250 |

Manufacturing

| -22.51% | O: -0.35% H: 0.07% C: -0.14%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -8.71% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 4.02% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| -6.93% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -5.26% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 6.67% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

---

Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -1.24% | O: -2.34% H: 0.43% C: 0.43%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -0.68% | O: -2.16% H: 1.17% C: 1.17%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -11.52% | O: 0.46% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| -0.77% | O: 0.17% H: 1.33% C: 0.94%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -9.33% | O: -0.96% H: 0.3% C: 0.28%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 3.36% | O: -0.76% H: 0.38% C: 0.13%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 2.22% | O: 0.37% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| -7.0% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -7.21% | O: -2.05% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 6.05% | O: -1.27% H: 0.8% C: 0.69%
drug hospital infection therapeutics growth market

---

Gainers vs Losers

58%

42%

Top 10 Gainers

BOF | $2.08 77.78% 39.06% 110M |

OPTN | $0.9253 -4.38% 30.38% 5.3M |

Health Services

SGBX | $0.1441 -2.24% 29.47% 6.1M |

Producer Manufacturing

PCSA | $1.62 1.25% 21.95% 7.1M |

Producer Manufacturing

BHIL | $0.1793 -4.37% 19.24% 340K |

Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K |

CI | $352.28 -0.11% 13.53% 2 |

Health Services

SPCB | News 4 d | $0.2236 -6.83% 12.09% 20M |

Electronic Technology

BMTX 4 | $1.545 0.98% 10.03% 2.5K |

Information

OMQS | $0.411 -2.81% 9.83% 1.2M |

Professional, Scientific, and T...

---

Your saved searches

---